Venous Thromboembolism Requiring Extended Anticoagulation Among HIV-Infected Patients in a Rural, Resource-Constrained Setting in Western Kenya

Annals of Pharmacotherapy

Volumn 51, Issue 5, 2017, Pages 380-387

  Kanyi, John ^a,b   Karwa, Rakhi ^b,c,d   Pastakia, Sonak Dinesh ^b,c,d   Manji, Imran ^a,b   Manyara, Simon ^a,b   Saina, Collins ^b  

^a MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^b ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^c PURDUE UNIVERSITY   (United States)

^d MOI UNIVERSITY   (Kenya)

Author keywords

extended anticoagulation; HIV; Sub Saharan Africa; venous thromboembolism; warfarin

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTICOAGULANT AGENT; ANTIVITAMIN K; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RIFAMPICIN; TUBERCULOSTATIC AGENT; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIRETROVIRAL THERAPY; ARTICLE; BLEEDING; CD4 LYMPHOCYTE COUNT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL NORMALIZED RATIO; KENYA; LOWER EXTREMITY DEEP VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; SOCIAL STATUS; TREATMENT DURATION; TUBERCULOSIS; VIRUS LOAD; COMPLICATION; DIAGNOSTIC IMAGING; DOPPLER ULTRASONOGRAPHY; HEALTH CARE ORGANIZATION; HIV INFECTIONS; MEDICAL RECORD; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; RETROSPECTIVE STUDY; RURAL POPULATION; STANDARDS; TIME FACTOR; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

ADULT; ANTICOAGULANTS; FEMALE; HEALTH CARE RATIONING; HIV INFECTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; KENYA; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN;

EID: 85016950433     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028016686106     Document Type: Article

References (24)

1. UNAIDS. Fact sheet November 2016. http://www.unaids.org/en/resources/fact-sheet. Accessed September 21, 2016.
2. Palella FJ, Jr Baker RK, Moorman AC. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34.
3. Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis [published online February 10, 2016]. Int J STD AIDS.
4. Crum NF, Riffenburgh RH, Wegner S. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
5. Bibas M, Biava G, Antinori A., HIV-associated venous thromboembolism. Mediterr J Hematol Infect Dis. 2011;3:e2011030.
6. Klein SK, Slim EJ, de Kruif MD. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005;63:129-136.
7. Crum-Cianflone NF, Weekes J, Bavaro M., Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS. 2008;22:771-778.
8. Kuller LH, Tracy R, Belloso W, ; INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.
9. Kiser KL, Badowski ME., Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection. Pharmacotherapy. 2010;30:1292-1302.
10. Sullivan PS, Dworkin MS, Jones JL, Hooper WC., Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS. 2000;14:321-324.
11. Wester CW, Koethe JR, Shepherd BE. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS. 2011;25:1471-1479.
12. AMPATH. Leading with care. http://www.ampathkenya.org. Accessed January 24, 2014.
13. Einterz RM, Kimaiyo S, Mengech HN. Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med. 2007;82:812-818.
14. Manji I, Pastakia SD, Do AN. Performance outcomes of a pharmacist-managed anticoagulation clinic in the rural, resource-constrained setting of Eldoret, Kenya. J Thromb Haemost. 2011;9:2215-2220.
15. Kearon C, Kahn SR, Agnelli G. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:454S-545S.
16. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E., A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-239.
17. Kaatz S., Determinants and measures of quality in oral anticoagulation therapy. J Thromb Thrombolysis. 2008;25:61-66.
18. Ageno W, Samperiz A, Caballero R. Duration of anticoagulation after venous thromboembolism in real world clinical practice. Thromb Res. 2015;135:666-672.
19. Kearon C, Akl EA, Comerota AJ. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S-e494S.
20. Kearon C, Akl EA, Ornelas J. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149:315-352.
21. Brighton TA, Eikelboom JW, Mann K. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367:1979-1987.
22. Becattini C, Agnelli G, Schenone A. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012;366:1959-1967.
23. Simes J, Becattini C, Agnelli G. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation. 2014;130:1062-1071.
24. Anderson AM, Chane T, Patel M, Chen S, Xue W, Easley KA., Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals. AIDS Patient Care STDS. 2012;26:454-462.